Literature DB >> 6378251

High accuracy (stable isotope dilution) measurements of lead in serum and cerebrospinal fluid.

W I Manton, J D Cook.   

Abstract

The concentration of lead in blood, serum, cerebrospinal fluid, and urine was measured in patients with neurological disease and in control subjects including cases of plumbism. A plot of blood lead versus serum lead resembles the familiar curves of blood lead versus either free erythrocyte porphyrin or urinary delta-aminolaevulinic acid in that serum lead is constant up to a blood lead concentration of 40 micrograms/dl (2 mumol/l) and rises steeply thereafter. The serum lead concentrations yield renal clearances in the range 5-22 ml/min in agreement with values obtained with radiolead on man and predicted from animal studies. The lead content of cerebrospinal fluid is consistently less than that of serum, averaging 50% of the serum concentration for blood leads of less than 20 micrograms/dl (1 mumol/l) but rising to 80-90% in cases of plumbism. Patients with motor neurone disease could not be distinguished from those with other neurological diseases on the basis of the lead content of their serum or cerebrospinal fluid.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378251      PMCID: PMC1069351          DOI: 10.1136/oem.41.3.313

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  18 in total

1.  The distribution of inorganic lead in guinea pig brain and neural barrier tissues in control and lead-poisoned animals.

Authors:  L A O'Tuama; C S Kim; J T Gatzy; M R Krigman; P Mushak
Journal:  Toxicol Appl Pharmacol       Date:  1976-04       Impact factor: 4.219

2.  Chronic neurological disease as a possible form of lead poisoning.

Authors:  E J BUTLER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1952-05       Impact factor: 10.154

3.  A micromethod for free erythrocyte porphyrins: the FEP test.

Authors:  S Piomelli
Journal:  J Lab Clin Med       Date:  1973-06

4.  Interrelationships between lead in blood, lead in urine, and ALA in urine during lead work.

Authors:  S Selander; K Cramér
Journal:  Br J Ind Med       Date:  1970-01

5.  "ULtra-clean" isotope diultion/mass spectrometic analyses for lead in human blood plasma indicated that most reported values are artificially high.

Authors:  J Everson; C C Patterson
Journal:  Clin Chem       Date:  1980-10       Impact factor: 8.327

6.  Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry.

Authors:  S Conradi; L O Ronnevi; O Vesterberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-05       Impact factor: 10.154

7.  Response to penicillamine of lead concentrations in CSF and blood in patients with motor neurone disease.

Authors:  A O House; R J Abbott; D L Davidson; I T Ferguson; J A Lenman
Journal:  Br Med J       Date:  1978-12-16

8.  Abnormal distribution of lead in amyotrophic lateral sclerosis--reestimation of lead in the cerebrospinal fluid.

Authors:  S Conradi; L O Ronnevi; G Nise; O Vesterberg
Journal:  J Neurol Sci       Date:  1980-12       Impact factor: 3.181

9.  The concentration of lead in plasma, whole blood and erythrocytes of infants and children.

Authors:  M J ROBINSON; F E KARPINSKI; H BRIEGER
Journal:  Pediatrics       Date:  1958-05       Impact factor: 7.124

10.  Abnormal tissue distribution of lead in amyotrophic lateral sclerosis.

Authors:  S Conradi; L O Ronnevi; O Vesterberg
Journal:  J Neurol Sci       Date:  1976-10       Impact factor: 3.181

View more
  15 in total

1.  Measurement by ICP-MS of lead in plasma and whole blood of lead workers and controls.

Authors:  A Schütz; I A Bergdahl; A Ekholm; S Skerfving
Journal:  Occup Environ Med       Date:  1996-11       Impact factor: 4.402

2.  Neuropathological lesions in the brains of goats in North-Western Nigeria: possible impact of artisanal mining.

Authors:  Afusat J Jubril; Adedunsola A Obasa; Shehu A Mohammed; James O Olopade; Victor O Taiwo
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-15       Impact factor: 4.223

3.  Placental and lactational transfer of lead in rats: a study on the lactational process and effects on offspring.

Authors:  I P Hallén; L Jorhem; A Oskarsson
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

4.  Lead transport and binding by human erythrocytes in vitro.

Authors:  T J Simons
Journal:  Pflugers Arch       Date:  1993-05       Impact factor: 3.657

5.  Influence of bone resorption on the mobilization of lead from bone among middle-aged and elderly men: the Normative Aging Study.

Authors:  S W Tsaih; S Korrick; J Schwartz; M L Lee; C Amarasiriwardena; A Aro; D Sparrow; H Hu
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

6.  The relationship between lead in plasma and whole blood in women.

Authors:  Donald Smith; Mauricio Hernandez-Avila; Martha Maria Téllez-Rojo; Adriana Mercado; Howard Hu
Journal:  Environ Health Perspect       Date:  2002-03       Impact factor: 9.031

7.  Accumulated body burden and endogenous release of lead in employees of a lead smelter.

Authors:  D E Fleming; D Boulay; N S Richard; J P Robin; C L Gordon; C E Webber; D R Chettle
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

Review 8.  Uses and limits of empirical data in measuring and modeling human lead exposure.

Authors:  P Mushak
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

9.  The independent contribution of bone and erythrocyte lead to urinary lead among middle-aged and elderly men: the normative aging study.

Authors:  S W Tsaih; J Schwartz; M L Lee; C Amarasiriwardena; A Aro; D Sparrow; H Hu
Journal:  Environ Health Perspect       Date:  1999-05       Impact factor: 9.031

Review 10.  An age-specific kinetic model of lead metabolism in humans.

Authors:  R W Leggett
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.